-
Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase...
TheStreet.com | 05/20/13 - 09:15 AM EDT
-
Neuralstem CEO, Richard Garr, To Present At Annual World Stem Cells And Regen...
TheStreet.com | 05/16/13 - 09:15 AM EDT
-
DiagnoCure Announces Presentation On Previstage GCC At The 2013 ASCO Annual M...
TheStreet.com | 05/16/13 - 07:30 AM EDT
-
Neuralstem Principal Investigator, Dr. Eva Feldman, Presents Phase I ALS Tria...
TheStreet.com | 05/13/13 - 09:15 AM EDT
-
5 Stocks Under $10 Set to Soar
TheStreet.com | 05/09/13 - 01:49 PM EDT
-
5 Stocks Under $10 Set to Soar
Stockpickr | 05/09/13 - 01:46 PM EDT
-
Neuralstem ALS Trial Investigator And Patient On Sirius XM
TheStreet.com | 05/08/13 - 09:15 AM EDT
-
Neuralstem ALS Trial Data Presented At The American Association Of Neurologic...
TheStreet.com | 04/29/13 - 11:15 AM EDT
-
DiagnoCure's Update Presentation During The Annual And Special Meeting Of Sha...
TheStreet.com | 04/29/13 - 07:30 AM EDT
-
Neuralstem And The National Football League Alumni Association Announce Initi...
TheStreet.com | 04/24/13 - 09:15 AM EDT
-
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Ma...
TheStreet.com | 04/22/13 - 09:15 AM EDT
-
Neuralstem CEO, Richard Garr, To Participate In Traumatic Brain Injury Panel ...
TheStreet.com | 04/18/13 - 09:15 AM EDT
-
Neuralstem Receives FDA Approval To Commence Phase II Stem Cell Trial In Amyt...
TheStreet.com | 04/17/13 - 08:02 AM EDT
-
Nominations Pursuant To Advance Notice Policy
TheStreet.com | 04/15/13 - 07:30 AM EDT
-
DiagnoCure's Adoption Of An Advance Notice Policy
TheStreet.com | 04/09/13 - 08:26 AM EDT
-
Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells ...
TheStreet.com | 04/05/13 - 09:15 AM EDT
-
DiagnoCure Begins Trading On OTCQX®
TheStreet.com | 04/02/13 - 07:00 AM EDT
-
DiagnoCure Joins The OTCQX Marketplace And S&P Corporation Records Listing
TheStreet.com | 04/02/13 - 07:00 AM EDT
-
Neuralstem Secures $8 Million In Debt Financing From Hercules
TheStreet.com | 03/25/13 - 09:15 AM EDT
-
Neuralstem CEO, Richard Garr, Named To "Top 50 Global Stem Cell Influencers"
TheStreet.com | 03/14/13 - 09:02 AM EDT
-
Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Device...
TheStreet.com | 02/20/13 - 09:15 AM EST
-
Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
TheStreet.com | 02/07/13 - 09:00 AM EST
-
Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial
TheStreet.com | 01/14/13 - 08:00 AM EST
-
DiagnoCure To Host Q4 2012 And Full Year Earnings Conference Call And Webcast
TheStreet.com | 01/07/13 - 07:30 AM EST
-
Neuralstem President And CEO To Present 2013 Trials Overview At 2013 Biotech ...
TheStreet.com | 01/04/13 - 09:00 AM EST
-
Neuralstem Investigator Presents New ALS NSI-566 Data At International Sympos...
TheStreet.com | 12/10/12 - 09:15 AM EST
-
4 Biotech Stocks Under $10 Moving Higher
TheStreet.com | 11/27/12 - 02:54 PM EST
-
4 Biotech Stocks Under $10 Moving Higher
Stockpickr | 11/27/12 - 02:53 PM EST
-
Diagnocure Announces Changes To Its Board Of Directors
TheStreet.com | 11/26/12 - 07:30 AM EST
-
FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In M...
TheStreet.com | 10/17/12 - 09:15 AM EDT